---
title: "AI-Driven Antibody Discovery DDup #11"
description: "hide gateway
Read the publication.AI-Driven Antibody Discovery. Contact Evotec to learn more!"
image: https://news.cyprotex.com/hubfs/Sciencepool/Sciencepool%20images/Inhouse%20images/DDup-11-mockup-science-pool.jpg
---

[![Cyprotex | The Leading ADME-Tox Specialist](https://news.cyprotex.com/hs-fs/hubfs/cyprotex%20logo.png?width=224&height=62&name=cyprotex%20logo.png "Cyprotex | The Leading ADME-Tox Specialist")](https://www.cyprotex.com/)

# Science Pool

# AI-Driven Antibody Discovery DDup #11

Posted by [Evotec](https://news.cyprotex.com/sciencepool/author/evotec) on Jan 4, 2022 3:42:49 PM

The 11th edition of our Drug Discovery Update (DDup) is dedicated to biotherapeutics discovery and development with a focus on artificial intelligence and machine learning and its opportunity in transforming antibody discovery.

In this edition, it covers:

- an introduction to antibodies including: 
    - an overview of monoclonal antibodies as therapeutic agents
    - a history of antibody drug discovery platforms
- how Just - Evotec Biologics are exploiting artificial intelligence and machine learning to generate a novel humanoid antibody library biased towards highly desirable features
- a description of the process from idea to IND and beyond for antibody discovery and development
- facts and figures on the market for therapeutic antibodies
- an overview of function-focused antibody (FFmab) screening
- an interviews with the experts

[LEARN MORE](https://www.evotec.com/en/invest/news--announcements/press-releases/p/evotec-publishes-ddup-11---ai-driven-antibody-discovery-at-evotec-6098)

 

 Tags: [Articles & Whitepapers](https://news.cyprotex.com/sciencepool/tag/articles-whitepapers), [Biologics](https://news.cyprotex.com/sciencepool/tag/biologics)